Showing results (6901-6910 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|September 6, 2014
Mycobacterium w Immunotherapy for Treating Pulmonary Tuberculosis - a Systematic ReviewShaheen Pandie, Mark E Engel, Zita S Kerbelker, et al.Current Pharmaceutical Design|September 25, 2014
The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral IschemiaMaría Isabel Cuartero, Juan de la Parra, Alicia García-Culebras, et al.Current Pharmaceutical Design|November 27, 2012
Gene polymorphism of angiotensin II type 1 and type 2 receptorsTomohiro Katsuya, Ryuichi MorishitaCurrent Pharmaceutical Design|November 27, 2012
The pharmacological effects of novokinin; a designed peptide agonist of the angiotensin AT2 receptorMasaaki Yoshikawa, Kousaku Ohinata, Yuko YamadaCurrent Pharmaceutical Design|November 27, 2012
Angiotensin (1-7) and other angiotensin peptidesMitsuru Ohishi, Koichi Yamamoto, Hiromi RakugiCurrent Pharmaceutical Design|November 28, 2012
Non-covalent proteasome inhibitorsJulia Kaffy, Guillaume Bernadat, Sandrine OngeriCurrent Pharmaceutical Design|October 22, 2013
Irreversible EGFR inhibitors in the treatment of advanced NSCLCPaolo Maione, Antonio Rossi, Marianna Bareschino, et al.Current Pharmaceutical Design|October 22, 2013
Signaling pathways modulating dependence of lung cancer on mutant epidermal growth factor receptor and mechanisms of intrinsic and acquired resistance to tyrosine kinase inhibitorsLuciano Wannesson, Santiago Viteri, Carlota Costa, et al.Current Pharmaceutical Design|November 20, 2013
Recent advances in QSAR-based identification and design of anti-tubercular agentsNidhi, Mohammad Imran SiddiqiCurrent Pharmaceutical Design|November 21, 2013
The role of melatonin in pancreatic protection: could melatonin be used in the treatment of acute pancreatitis?Jolanta Jaworek, Anna Leja-Szpak, Michalina Kot, et al.Pageof 1,009